Oracle Investment Management as of March 31, 2014
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 30 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Accelr8 Technology | 11.9 | $104M | 4.8M | 21.81 | |
| Quidel Corporation | 10.2 | $89M | 3.3M | 27.30 | |
| Tenet Healthcare Corporation (THC) | 8.6 | $75M | 1.8M | 42.81 | |
| Acorda Therapeutics | 8.5 | $74M | 2.0M | 37.91 | |
| Mazor Robotics Ltd. equities | 7.5 | $65M | 3.2M | 20.44 | |
| Thoratec Corporation | 7.2 | $63M | 1.8M | 35.81 | |
| Opko Health (OPK) | 5.9 | $52M | 5.6M | 9.32 | |
| Hansen Medical | 5.8 | $51M | 20M | 2.60 | |
| NxStage Medical | 5.2 | $46M | 3.6M | 12.74 | |
| Transition Therapeutics | 3.9 | $34M | 4.3M | 7.97 | |
| Accuray Incorporated (ARAY) | 3.5 | $31M | 3.2M | 9.60 | |
| Ironwood Pharmaceuticals (IRWD) | 2.6 | $23M | 1.8M | 12.32 | |
| Repros Therapeutics | 2.5 | $22M | 1.2M | 17.74 | |
| Vermillion | 2.4 | $21M | 7.1M | 2.95 | |
| Tesaro | 2.1 | $19M | 634k | 29.48 | |
| Endocyte | 1.8 | $16M | 670k | 23.81 | |
| Biolase Technology | 1.7 | $15M | 6.1M | 2.41 | |
| Intrexon | 1.6 | $15M | 550k | 26.29 | |
| Pacific Biosciences of California (PACB) | 1.6 | $14M | 2.6M | 5.35 | |
| WebMD Health | 1.4 | $12M | 300k | 41.40 | |
| Gentiva Health Services | 0.9 | $7.7M | 848k | 9.12 | |
| Derma Sciences | 0.7 | $6.3M | 500k | 12.68 | |
| Amarin Corporation (AMRN) | 0.6 | $5.4M | 3.0M | 1.81 | |
| Agenus (AGEN) | 0.5 | $4.4M | 1.4M | 3.17 | |
| Agios Pharmaceuticals (AGIO) | 0.5 | $3.9M | 100k | 39.15 | |
| Biogen Idec (BIIB) | 0.4 | $3.5M | 12k | 305.87 | |
| Metabolix | 0.2 | $2.2M | 1.7M | 1.30 | |
| GTx | 0.1 | $762k | 498k | 1.53 | |
| Ladenburg Thalmann Financial Services | 0.1 | $504k | 167k | 3.02 | |
| Gilead Sciences (GILD) | 0.0 | $99k | 50k | 1.98 |
